143 related articles for article (PubMed ID: 27847096)
21. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
Cardot-Bauters C; Leteurtre E; Leclerc L; Vantyghem MC; Do Cao C; Wemeau JL; d'Herbomez M; Carnaille B; Barbu V; Pinson S; Pigny P;
Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
[TBL] [Abstract][Full Text] [Related]
22. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
23. Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost.
Lindsey SC; Kunii IS; Germano-Neto F; Sittoni MY; Camacho CP; Valente FO; Yang JH; Signorini PS; Delcelo R; Cerutti JM; Maciel RM; Dias-da-Silva MR
Horm Cancer; 2012 Aug; 3(4):181-6. PubMed ID: 22648435
[TBL] [Abstract][Full Text] [Related]
24. New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma.
Dvoráková S; Václavíková E; Sýkorová V; Dusková J; Vlcek P; Ryska A; Novák Z; Bendlová B
Thyroid; 2006 Mar; 16(3):311-6. PubMed ID: 16571096
[TBL] [Abstract][Full Text] [Related]
25. Novel RET mutations in macedonian patients with medullary thyroid carcinoma: genotype-phenotype correlations.
Jovanovic R; Kostadinova-Kunovska S; Janevska V; Bogoeva B; Spasevska L; Miladinova D; Ugrinska A; Zdraveska-Kochovska M; Trajkov D; Petrusevska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):93-107. PubMed ID: 26076779
[TBL] [Abstract][Full Text] [Related]
26. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
28. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
29. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
30. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
[TBL] [Abstract][Full Text] [Related]
31. The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature.
Blom CB; Ceolin L; Romitti M; Siqueira D; Maia AL
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):586-91. PubMed ID: 23295303
[TBL] [Abstract][Full Text] [Related]
32. Sporadic minute medullary thyroid carcinoma with a double RET mutation: A case report.
Yamamoto H; Ishii J; Chiba T; Nakazato Y; Hirano K; Kamma H
Pathol Int; 2017 Nov; 67(11):580-584. PubMed ID: 28952196
[TBL] [Abstract][Full Text] [Related]
33. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
Abdelhakim A; Barlier A; Kebbou M; Benabdeljalil N; Timinouni M; Taoufiq F; Roche C; El Antri S
J Cancer Res Ther; 2009; 5(3):198-202. PubMed ID: 19841562
[TBL] [Abstract][Full Text] [Related]
34. The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review.
Fussey JM; Vaidya B; Kim D; Clark J; Ellard S; Smith JA
Clin Endocrinol (Oxf); 2019 Dec; 91(6):697-707. PubMed ID: 31301229
[TBL] [Abstract][Full Text] [Related]
35. Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.
Moura MM; Cavaco BM; Pinto AE; Domingues R; Santos JR; Cid MO; Bugalho MJ; Leite V
Br J Cancer; 2009 Jun; 100(11):1777-83. PubMed ID: 19401695
[TBL] [Abstract][Full Text] [Related]
36. Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan.
Chang CF; Yang WS; Su YN; Wu IL; Chang TC
J Formos Med Assoc; 2009 May; 108(5):402-8. PubMed ID: 19443294
[TBL] [Abstract][Full Text] [Related]
37. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
[No Abstract] [Full Text] [Related]
38. Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.
Lennon P; Deady S; White N; Lambert D; Healy ML; Green A; Kinsella J; Timon C; O' Neill JP
Ir J Med Sci; 2017 Feb; 186(1):89-95. PubMed ID: 27083464
[TBL] [Abstract][Full Text] [Related]
39. Child with RET proto-oncogene codon 634 mutation.
İnce D; Demirağ B; Ataseven E; Oymak Y; Tuhan H; Karakuş OZ; Hazan F; Abacı A; Özer E; Mutafoglu K; Olgun N
Turk J Pediatr; 2017; 59(5):590-593. PubMed ID: 29745123
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
Moura MM; Cavaco BM; Pinto AE; Leite V
J Clin Endocrinol Metab; 2011 May; 96(5):E863-8. PubMed ID: 21325462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
